Human sphingosine-1-phosphate phosphatase and inhibition methods
US7374889B2 · kind B2 · utility
0Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2002 |
| Grant date | May 20, 2008 |
| Priority date | — |
| Expiry date | Apr 25, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2217/05
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides polynucleotides and polypeptides of a human sphingosine-1-phosphate phosphatase, referred to herein as hSPP1. The polynucleotides and polypeptides are used to further provide expression vectors, host cells comprising the vectors, probes and primers, antibodies against the hSPP1 protein and polypeptides thereof, assays for the presence or expression of hSPP1 and assays for the identification of compounds that interact with hSPP1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.